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We have previously shown that traumatic brain injury (TBI) can induce an upregulation of nuclear factor kappa B (NF-κB) and
proinﬂammatory cytokines in the gut, which play an important role in the pathogenesis of acute gut mucosal injury mediated by
inﬂammation. In this work, we investigated whether progesterone administration modulated intestinal NF-κB activity and proin-
ﬂammatory cytokines expression after TBI in male rats. As a result, we found that administration of progesterone following TBI
could decrease NF-κB binding activity, NF-κB p65 protein expression, and concentrations of interleukin-1β (IL-1β), and tumor
necrosis factor-α (TNF-α) in the gut. TBI-induced damages of gut structure were ameliorated after progesterone injections. The
results of the present study suggest that the therapeutic beneﬁt of post-TBI progesterone injections might be due to its inhibitory
eﬀects on intestinal NF-κB activation and proinﬂammatory cytokines expression.
Copyright © 2007 Gang Chen et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1. INTRODUCTION
Theimportanceoftheintestinalmucosaintheinﬂammatory
and metabolic responses to sepsis, trauma, and other critical
illnesses is increasingly recognized. Major trauma and shock
may initiate a cascade of intestinal events such as intestinal
cytokine overproduction [1], increased intestinal permeabil-
ity [2], and translocation of intestinal bacteria and endotox-
ins [3]. These events may not only inﬂuence the intestinal
mucosa itself, but also may aﬀect the function and integrity
of remote organs and tissues, leading to systemic inﬂamma-
tory response syndrome (SIRS) and multiple organ dysfunc-
tion syndrome (MODS). In our previous study [4], it has
been demonstrated that traumatic brain injury (TBI) can in-
duce marked damage of intestinal mucosa structure includ-
ing the shedding of epithelial cells, fracture of villi, focal ul-
ceration, fusion of adjacent villi, dilation of the central chyle
duct, mucosal atrophy, and disruption of the tight junction
between enterocytes. Afterwards, we found that inﬂamma-
tory response mediated by increased nuclear factor kappa
B( N F - κB) and proinﬂammatory cytokines played a crucial
pathological role in acute gut mucosal injury following TBI
[5]. However, little information was found in the literatures
about any eﬀective treatment that could modulate intestinal
NF-κB activation and proinﬂammatory cytokines produc-
tion after TBI.
Since its identiﬁcation as an inducible activator of gene
transcription from the intronic κ light chain, the nuclear
transcription factor, NF-κB, has been implicated in the regu-
lation of a growing number of gene products that contribute
to the pathogenesis of numerous clinical disorders [6]. NF-
κB functions as homo- or heterodimers of the Rel family of
proteins, which includes p50, p65, c-Rel, p52, and RelB [7].
Themostcommoncombinationofsubunitsisahererodimer
of the p50 and p65 proteins. NF-κB normally exists in the cy-
toplasm of cells bound by a member of the inhibitor kappa B
(I-κB) protein family. NF-κB activation by inducers, such as
IL-1β [7,8]andTNF -α[9],leadstophosphorylationandde-
gration of the I-κB protein allowing NF-κB translocation to
the nucleus where it can then bind to speciﬁc sites within the
promoter sequence of target genes whose products, such as
proinﬂammatory cytokines, inducible nitric oxide synthase
(iNOS), cyclooxygenase-2 (COX-2), and acute phase pro-
teins, are critical to inﬂammatory processes [10, 11]. This
kind of positive feedback in the interaction of NF-κBw i t h
proinﬂammatory cytokines may occur through extracellu-
lar mechanisms, which has been conﬁrmed by several stud-
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TNF-α and IL-1β, and both of these cytokines are known to
inturnactivateNF-κB[14].Thepositivefeedbackisbelieved
to serve to amplify inﬂammatory signals.
Several experimental studies have demonstrated that
progesterone played neuroprotective roles in TBI including
reducing cerebral edema, preventing neuronal loss, and im-
proving functional outcomes [15, 16]. One of the speciﬁc
mechanisms by which progesterone acts to promote mor-
phological and functional recovery is via inhibiting the TBI-
induced cerebral NF-κB activation and proinﬂammatory cy-
tokines up-regulation [17, 18]. Nevertheless till now, no
study was found in the literature to investigate the eﬀects of
progesterone on intestinal expression of NF-κB and proin-
ﬂammatory cytokines. In the present study, we investigated
the inﬂuence of progesterone administration on NF-κBa c -
tivity and proinﬂammatorycytokines expression in thesmall
bowl following TBI in male rats.
2. MATERIALS AND METHODS
2.1. Animals
Male Wistar rats (300 to 350g) were purchased from Animal
Center of Chinese Academy of Sciences, Shanghai, China.
The rats were housed in temperature and humidity con-
trolled animal quarters with a 12-hour light/dark cycle. All
procedures were approved by the Institutional Animal Care
Committeeandwereinaccordancewiththeguidelinesofthe
National Institutes of Health on the care and use of animals.
2.2. Experimentprotocol
Rat model of cortical contusion trauma: following intraperi-
toneal anesthesia with urethane (1000mg/kg), animal head
was ﬁxed in the stereotactic frame. A right parietal cran-
iotomy (diameter 5mm) was drilled under aseptic condi-
tions 1mm posterior and 2mm lateral to the bregma. We
used a modiﬁcation of the Feeney’s weight-drop model [19]
in which a freefalling weight onto the exposed intact cranial
dura produced a standardized parietal contusion by letting
a steel rod weighing 40g with a ﬂat end diameter of 4mm
fall onto a piston resting on the dura from a height of 25cm.
The piston was allowed to compress the tissue a maximum
of 5mm. After operation procedures, the rats were then re-
turned to their cages and the room temperature was kept
at 23 ± 1◦C. Heart rate, arterial blood pressure and rectal
temperature were monitored, and the rectal temperature was
kept at 37 ± 0.5◦C, by using physical cooling (ice bag) when
required, throughout experiments. Sham-operated rats were
anesthetized, mounted in the stereotaxic apparatus, and had
their scalps cut and sutured but were not trephinated.
The experimental groups consisted of sham + vehicle
(SV; n = 6), lesion + vehicle (LV; n = 6), and lesion + pro-
gesterone (LP; n = 6 ) .R a t so fL Pg r o u pr e c e i v e di n j e c t i o n s
of 16mg/kg progesterone (4-Pregnene-3, 20-dione, Sigma-
aldrich Inc., St. Louis, MO, USA) at 1 and 6 hours and 1, 2, 3,
4, and 5 days after the surgery (intraperitoneally for the ﬁrst
andsubcutaneouslyfortheremainingsix).RatsofSVandLV
groups received equal volumes of vehicle (2-hydroxypropyl-
β-cyclodextrin, Sigma-aldrich Inc.) [20, 21]. The animals
were decapitated 5 days after injury for tissue assays. A 3-cm
segment of the mid-ileum was taken and ﬂushed with ice-
cold saline. Half of it was immersed in neutral-buﬀered for-
malin for immunohistochemical assay and histopathological
study. The other was stored in liquid nitrogen immediately
for electrophoretic mobility shift assay (EMSA) and enzyme-
linked immunosorbent assay (ELISA).
2.3. NuclearproteinextractandEMSA
Nuclear protein was extracted and quantiﬁed as described
[5]. EMSA was performed using a commercial kit (Gel Shift
Assay System; Promega, Madison, WI, USA) following the
methodsinourlaboratory.TheNF-κBoligonucleotideprobe
(5’-AGTTGAGGGGACTTTCCCAGGC-3’) was end-labeled
with [γ-32P] ATP (Free Biotech, Beijing, China). EMSA was
performed according to our previous study [5]. After elec-
trophoresis, the gel was transferred to Whatman ﬁlter paper,
vacuum dried and exposed to Kodak XAR-5 ﬁlm overnight.
Levels of NF-κB DNA binding activity were quantiﬁed by
scanning the developed Kodak XAR-5 ﬁlm with a computer-
assisted, linear scanning densitometer in transparent mode
(Hoefer Scientiﬁc Instruments, San Francisco, CA, USA).
Data were expressed as arbitrary densitometry units (ADU)
obtained from the densitometric scans.
2.4. DetectionofNF-κBp65andp50expressionin
ileumtissue
Immunohistochemical studies were conducted on formalin-
ﬁxed, paraﬃn-embedded sections. The rabit-anti-rat mono-
clonalantibodiesofNF-κBp65andp50(bothdiluted1:100,
SantaCruzBiotechnology,Inc.,CA,USA)wereused.Forim-
munohistochemistry, sections were incubated in phosphate-
buﬀeredsaline (PBS)with5% normal horse serumand0.3%
Triton X-100 for 1 hour at room temperature. Sections were
washedthreetimeswithPBSandincubatedwithprimaryan-
tibody for 2 hours at room temperature. After washing with
PBS, sections were incubated with biotinylated second anti-
bodies for 1 hour at room temperature. Sections incubated
in the absence of primary antibody were used as negative
controls. Microscopy of the immunohistochemically stained
tissue sections was performed by an experienced pathologist
blinded to the experimental condition. Therfore, evaluation
ofsectionswasundertakenbyassessingtheintensityofstain-
ing (5 grades). “0” indicates that there were no detectable
positive cells; “1” indicates very low density of positive cells;
“2” indicates a moderate density of positive cells; “3” indi-
cates the higher, but not maximal density of positive cells;
and “4” indicates the highest density of positive cells.
2.5. DetectionofIL-1βandTNF-αinileumtissue
The frozen ileum tissue was homogenized with a glass ho-
mogenizer in 1ml of buﬀer containing 1mmol/L of PMSF,
1mg/L of pepstatin A, 1mg/L of aprotinin, and 1mg/L of le-
upeptininPBSsolution(pH7.2)andcentrifugedat12000g.
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mediators were quantiﬁed using speciﬁc ELISA kits for rats
according to the manufacturers’ instructions (TNF-α from
Diaclone Research,France;IL-1β from Biosource Europe SA,
Belgium). The cytokine contents in the ileum tissue were ex-
pressed as nanograms of cytokines per gram of protein.
2.6. Histopathologicalexamination
The neutral-buﬀered formalin-ﬁxed ileum was embedded in
paraﬃn, sectioned at 4μm thickness with a microtome and
stained with hematoxylin and eosin (H and E). The sections
were examined under light microscope. Villous height, di-
ameter of middle villous segment, and crypt depth in all tis-
sues were determined using the HPIAS-1000 colorful image
analysis system (Champion Image Engineering Company,
Wuhan, China) [4]. Villous surface area was calculated ac-
cording to the following formula: surface area = πdh (d,
diameter; h, villous height). At least 10 well-oriented crypt-
villous units per small intestinal sample were measured and
averaged by a pathologist who was blind to animal groups.
2.7. Statisticalanalysis
The data were presented as mean ± SD. SPSS 12.0 was used
for statistical analysis of the data. The comparisons of NF-κB
p65 and p50 grades among various groups were conducted
by using Mann-Whitney U test. The other measurements
were analyzed by one-way ANOVA, followed by Tukey post
hoc test. Statistical signiﬁcance was inferred at P<. 05.
3. RESULTS
3.1. Generalobservations
Rats in SV group usually recover consciousness during 12
hours after anesthesia and sham operation, whereas rats in
both LV and LP groups were temporally unconscious for 48
hours post-injury and recovered almost normal eating be-
havior from 72 hours after cortical contusion trauma. Dur-
ing the period of unconsciousness, the rats were given 3ml
of water per 6 hours by tube feeding. After the right pari-
etal cortical contusion, the rats failed to fully extend the left
forepaw. The mean arterial blood pressure values and body
temperature were within the normal physiological range for
all animals (data not shown). The mean baseline weight of
the rats in the three groups did not signiﬁcantly diﬀer before
injury.
3.2. NF-κBbindingactivityintheileumtissue
EMSA autoradiography of NF-κB DNA binding activity of
the ileum tissue samples was shown in Figure 1.L o wN F - κB
bindingactivity(weakEMSAautoradiography)wasfoundin
the SV group. Compared with SV group, NF-κB binding ac-
tivity in the small bowl was signiﬁcantly increased (P<. 01)
in LV group. In LP group, intestinal NF-κB binding activ-
ity was signiﬁcantly down-regulated (P<. 05) after proges-
terone injections.
3.3. ExpressionofNF-κBp65andp50inileumtissue
The immunohistochemical assay showed lower NF-κBp 6 5
immunoreactivity in the lamina propia of the mucosa and
the interstitial region in SV group (see Figure 2). Compared
to SV group, NF-κB p65 was signiﬁcantly up-regulated (P<
.01) in villous interstitium and lamina propria following TBI
(see Figures 2 and 4). In LP group, the number of NF-κB
p65 immunoreactivity was signiﬁcantly decreased (P<. 05)
(see Figures 2 and 4). The results showed that progesterone
administration could signiﬁcantly down-regulate the NF-κB
p65immunoreactivityinratintestinefollowingTBI(seeFig-
ures 2 and 4). The NF-κB p50 expression in ileum was not
signiﬁcantly diﬀerent among groups of SV, LV, and LP, in
which there were very low NF-κB p50 immunoreactivity in
thevillousinterstitiumandlaminapropria(seeFigures3and
4).
3.4. IntestinallevelsofIL-1βandTNF-α
Concentrations of IL-1β and TNF-α were low in the rat gut
of SV group (1.85 ±0.56 and 2.23 ±0.21ng/g protein, resp.)
(see Figure 5). Compared with SV group, intestinal levels of
the two inﬂammatory cytokines were greatly induced after
TBI. As shown in Figure 5, progesterone administration after
TBI could lead to signiﬁcantly decreased IL-1β and TNF-α
concentrations (P<. 05) in rat ileum tissue.
3.5. Histomorphometricstudies
Villous height, crypt depth, and villous surface area were de-
termined as speciﬁc indices for the evaluation of mucosal
damages. The parameters are shown in Table 1. Quantitative
analyses of the villi demonstrated that the villous height and
crypt depth were signiﬁcantly decreased in LV group as com-
pared with SV group (P<. 05). In LP group, villous height
and crypt depth were increased signiﬁcantly as compared
with LV group (P<. 01). Although villous surface area was
not decreased signiﬁcantly in LV group, the intestinal villous
surfaceareawasincreased signiﬁcantly afterprogesteronein-
jections (P<. 05).
4. DISCUSSION
ThemajorchangesofgastrointestinalfunctionafterTBImay
be classiﬁed into four aspects: stress ulcer, gut motility dys-
function, disruption of gut barrier, and alterations of mu-
cosal absorptive function. We previously reported that trau-
matic brain injury could lead to signiﬁcant damages of gut
structure and impairment of barrier function [4]. The in-
testinal inﬂammatory response following TBI is character-
ized by intestinal recruitmentsof neutrophils and monocytes
through up-regulating of NF-κB and releasing proinﬂamma-
tory cytokines, which can lead to gut mucosal injury [5]. In
this present study, we found that progesterone administra-
tion could decrease the NF-κB binding activity, NF-κBp 6 5
protein expression and concentrations of IL-1β and TNF-α
in the small bowl following TBI. It was also demonstrated4 Mediators of Inﬂammation
SV LV LP
NF-κB
(a)
0
2
4
6
8
10
12
14
16
18
N
F
-
κ
B
b
i
n
d
i
n
g
a
c
t
i
v
i
t
y
(
A
D
U
)
SV LV LP
∗∗
#
(b)
Figure 1: NF-κB activity in the ileum tissue in SV group (sham + vehicle, n = 6), LV group (lesion + vehicle, n = 6), and LP group (lesion +
progesterone, n = 6). (Upper) EMSA autoradiography of NF-κB DNA binding. (Bottom) Levels of NF-κB DNA binding activity quantiﬁed
by computer-assisted densitometric scanning and expressed as an arbitrary densitometric units (ADU). As compared with SV group, NF-κB
binding activity measured by EMSA was signiﬁcantly increased in LV group. Compared to LV group, progesterone signiﬁcantly suppressed
NF-κB activation in LP group. ∗∗P<. 01 versus SV group, #P<. 05 versus LV group.
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Figure 2: Expression of NF-κB p65 in the small intestines in SV group (sham + vehicle, n = 6), LV group (lesion + vehicle, n = 6), and
LP group (lesion + progesterone, n = 6). (a) Rats of SV group showing low NF-κB p65 immunoreactivity; (b) Rats of LV group showing
increased NF-κB p65 immunoreactivity stained as brown; (c) Rats of LP group showing less NF-κB p65 immunoreactivity than LV group
(scar bar, 100μm).
that TBI-induced damages of gut structure were ameliorated
when treated with progesterone.
Steroids are known regulators of NF-κBa c t i v i t y[ 22, 23].
Previous studies of the anti-inﬂammatory properties of pro-
gesterone have been largely characterized in female repro-
ductive tissue, where progesterone down-regulates COX-2
via NF-κB inhibition [24, 25]. Progesterone has been re-
ported to inhibit NF-κB-mediated transcription in two ways.
The better-characterized route is by promoting the produc-
tion of the endogenous inhibitor of NF-κB( I - κB) [26]. Re-
centstudiesshowthat,whenprogesteroneispresent,thepro-
gesterone receptor forms a heterodimer with NF-κBp 6 5a n d
in turn inhibits binding of either transcription factor to its
binding site [23]. In this present study, we found the NF-
κB binding activity in the nuclear protein was induced by
TBI and repressed by progesterone administration. More-
over, we proved that the main up-regulated part of NF-κB
was the subunit p65, but not p50. After progesterone in-
jections, intestinal level of NF-κB p65 was decreased signif-
icantly. Although the current data have demonstrated that
progesteroneadministration suppressedtheTBI-inducedin-
testinal NF-κB up-regulation, changes about the expression
of progesterone receptor (PR) and the whole signaling path-
way in the gut remain unknown.
IntheresearchregardingprogesteroneandNF-κB,Pettus
et al. [18] used Western blot techniques to analyze the eﬀect
ofprogesteroneoncerebralexpressionofNF-κB. Theyfound
NF-κB p65 was increased in all injured animals and de-
creased by progesterone treatment in comparison to vehicle-
treated animals. Measures of NF-κB p50 showed no change
after injury or progesterone treatment. Horie et al. [27] in-
vestigated the inﬂuence of progesterone on NF-κBa c t i v a t i o n
in vitro and suggested that progesterone could reduce TNF-
α-induced NF-κB activation in endometriotic stromal cells.
Another in vitro study [28] demonstrated that progesterone
acted through multiple mechanisms to inhibit NF-κB. First,
there was direct inhibition of NF-κB binding to DNA by PR
which did not depend upon the presence of ligand and, pre-
sumably, was not related to the transcriptional activity of PR.
Second, through the isoform progesterone receptor B (PRB),
progesterone inhibited the transcription of tumor necrosis
factor-α related apoptosis inducing ligand (TRAIL, an acti-
vator of NF-κB), and through PRA + PRB, progesterone in-
hibited the transcription of its receptor, TRAILR2. Finally,Gang Chen et al. 5
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Figure 3: Expression of NF-κB p50 in the small intestines in SV group (sham + vehicle, n = 6), LV group (lesion + vehicle, n = 6), and LP
group (lesion + progesterone, n = 6). Very low NF-κB p50 immunoreactivity was shown in the ileum tissue of the three groups (scar bar,
100μm).
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Figure 4: NF-κB p65 and p50 grades in the small intestines in SV
group (sham + vehicle, n = 6), LV group (lesion + vehicle, n = 6),
and LP group (lesion + progesterone, n = 6). Administration of
progesterone remarkably inhibited TBI-induced up-regulation of
NF-κB p65 expression in rat ileum tissue. The NF-κBp 5 0e x p r e s -
sion in ileum was not signiﬁcantly diﬀerent among groups of SV,
LV and LP. ∗∗P<. 01 versus SV group; #P<. 05 versus LV group.
progesterone induced the transcription of A20 and ABIN-2
through PRB, resulting in the inactivation of free NF-κBi n
the cytoplasm.
Cytokinesarerecognizedassmallandnonstructuralpro-
teins, which are pleiotropic and have multiple diverse bio-
logical activities [29]. Several studies have demonstrated that
progesterone could modulate inﬂammatory cytokine pro-
d u c t i o ni nv i v oa n dv i t r o[ 30, 31]. As revealed by He et al.
[17], post-TBI progesterone administration might attenuate
the production of proinﬂammatory cytokines, such as IL-
1β and TNF-α, in the injured brain. Another research [32]
indicated that the abundant expression of TNF-α might be
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Figure 5: Changes of inﬂammatory mediators in the small in-
testines as determined by ELISA in SV group (sham + vehicle,
n = 6), LV group (lesion + vehicle, n = 6), and LP group (lesion +
progesterone, n = 6). TBI could induce the signiﬁcantly increased
concentrations of IL-1β and TNF-α in rat ileum tissue. In LP group,
the intestinal concentrations of IL-1β and TNF-α were markedly
down-regulated as compared with that of LV group. ∗∗P<. 01 and
∗P<. 05 versus SV group; #P<. 05 versus LV group.
a molecular basis characteristic of leiomyomas in the hu-
man uterus and that progesterone might play a vital role in
down-regulating the expression of TNF-α in human uter-
ine leiomyoma. Our study showed that intestinal TNF-α and
IL-1β levels were signiﬁcantly induced by TBI at 5 days af-
tertrauma.ProgesteroneadministrationfollowingTBIcould
down-regulate the expressions of TNF-α and IL-1β in the
gut. However, it is still unclear that how progesterone mod-
ulates the inﬂammatory signals and the whole mechanisms
involved call for further research.
In summary, to the best of our knowledge, this is the
ﬁrst study to demonstrate the eﬀects of progesterone on
the intestinal expression of inﬂammatory agents after TBI.
We found that progesterone administration could suppress6 Mediators of Inﬂammation
Table 1: Changes in villous height, diameter, crypt depth, and surface area of mucosa (Values were expressed as mean ± SD.)
Groups Villous height (μm) Villous diameter (μm) Crypt depth (μm) Surface area (mm2)
SV 294.1 ±41.86 3 .0 ±15.58 0 .2 ±12.50 .0577 ±0.0155
LV 216.8 ±12.3∗ 54.2 ±2.05 5 .2 ±1.8∗ 0.0370 ±0.0034
LP 257.5 ±40.3## 54.4 ±5.66 6 .5 ±1.6## 0.0448 ±0.0053#
∗P<. 05 versus SV group.
#P<. 05 and ##P<. 01 versus LV group.
the TBI-induced NF-κB activation in the gut, decrease the
intestinal production of proinﬂammatory cytokines, and
protect ileum mucosa structure. These results suggest that
the therapeutic beneﬁt of post-TBI progesterone injections
might be due to its inhibitory eﬀects on NF-κB activity and
proinﬂammatory cytokines expression in the small bowl.
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